HIGHLIGHTS
- who: Anna Embring from the (UNIVERSITY) have published the article: Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost, in the Journal: (JOURNAL)
- what: This study compares treatment and toxicity outcomes from two different boost modalities in oropharyngeal cancer: simultaneous integrated boost (SIB) and brachytherapy boost. In contrast to late mucosal ulcers, the incidence of late severe dysphagia (16.5%) seems higher in this study compared to previously published data. The side effects of dose escalation radiotherapy seen in this study will be further investigated in the next study, where . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.